BLU - Bellus Health Inc
Close
14.74
0 0%
Share volume: 0
Last Updated: Wed 28 Jun 2023 10:00:01 PM CEST
Pharmaceutical Preparation Manufacturing :
-2.88%
PREVIOUS CLOSE
CHG
CHG%
$14.74
0.00
0.00%
Summary score
25%
Profitability
35%
Dept financing
2%
Liquidity
47%
Performance
15%
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Long-term ratios 2016 - 2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-7.4%
Return on assets
-9.02%
Return on sales
-1923.65%
Return on invested capital
-54.03%
Total debt ratio
10.19%
Debt ratio change over timeo
-0.87%
Current Ratio
11.15%
Quick Ratio
0%
Cash Position Ratio
3.17%
Short-term ratios 2019 - 2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-11.52%
Return on assets
-10.27%
Return on sales
0%
Return on invested capital
113.49%
Total debt ratio
8.63%
Debt ratio change over timeo
-0.96%
Current Ratio
12.02%
Quick Ratio
0%
Cash Position Ratio
2.92%
Last quarter ratios 2020
The data are presented for the financials results of the last quarter.
Return on equity
-8.46%
Return on assets
-7.49%
Return on sales
0%
Return on invested capital
-23.76%
Total debt ratio
4%
Debt ratio change over time
-0.98%
Current Ratio
15.47%
Quick Ratio
0%
Cash Position Ratio
3.31%
Performance ratios (change over 4 years) 2016 - 2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-108.86%
Return on assets
-109.95%
Return on sales
-11378.72%
Return on invested capital
-186.62%
Total debt ratio
-87.26%
Debt ratio change over time
-0.87%
Current Ratio
3.4%
Quick Ratio
0%
Cash Position Ratio
0.65%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | BLU | VLON | ELAT | RETA |
---|---|---|---|---|
Return on equity | -7.4% | 0% | 0% | 32.94% |
Return on assets | -9.02% | 0% | 0% | -9.88% |
Return on sales | -1923.65% | 0% | 0% | -1451.74% |
Return on invested capital | -54.03% | 0% | 0% | 38.19% |
Profitability | 0% | 0% | 50% | 50% |
Total debt ratio | 10.19% | 0% | 0% | 191.06% |
Debt ratio change over time | -0.87% | 0% | 0% | 20.42% |
Dept financing | 1% | 0% | 0% | 50% |
Current Ratio | 12.02% | 0% | 0% | 3.57% |
Quick Ratio | 0% | 0% | 0% | 3.57% |
Cash Position Ratio | 2.92% | 0% | 0% | 3.48% |
Liquididy | 49% | 0% | 0% | 57% |
Short-term ratios | BLU | VLON | ELAT | RETA |
---|---|---|---|---|
Return on equity | -11.52% | 0% | 0% | 16.85% |
Return on assets | -10.27% | 0% | 0% | -15.81% |
Return on sales | 0% | 0% | 0% | -3194.77% |
Return on invested capital | 113.49% | 0% | 0% | 64.42% |
Profitability | 50% | 0% | 25% | 39% |
Total debt ratio | 8.63% | 0% | 0% | 91.27% |
Debt ratio change over time | -0.96% | 0% | 0% | 0.42% |
Dept financing | 2% | 0% | 0% | 50% |
Current Ratio | 12.02% | 0% | 0% | 3.57% |
Quick Ratio | 0% | 0% | 0% | 3.57% |
Cash Position Ratio | 2.92% | 0% | 0% | 3.48% |
Liquididy | 46% | 0% | 0% | 57% |